Lanean...
Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis
BACKGROUND: TAS-102 has been applied to metastatic colorectal cancer (mCRC) patients who had received at least two prior regimens of standard chemotherapy. This meta-analysis is designed to assess the efficacy and safety of TAS-102 in patients with mCRC. METHODS: We searched randomized controlled tr...
Gorde:
| Argitaratua izan da: | Cancer Manag Res |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6118256/ https://ncbi.nlm.nih.gov/pubmed/30214286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S174584 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|